Company intelligence / Profile preview
Trevena, Inc.
Chesterbrook, Pennsylvania, United States of Americatrevena.com ↗
- Ownership
- Public · TRVN
- Employees
- ~85
- Development stage
- Commercial
01
Overview
OLINVYK® was approved by FDA in August 2020 for intravenous treatment of acute moderate-to-severe post-operative pain with a novel G protein-biased mechanism at the mu-opioid receptor offering analgesia with potentially fewer adverse effects than morphine. Other pipeline candidates are in early clinical phases showing promising safety and tolerability data but remain investigational[6][7].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecule drugs
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
National Institute on Drug Abuse for development of TRV734licensing agreement with Jiangsu Nhwa Pharmaceutical for commercialization rights to Olinvyk in China
04
Financials
- Market cap
- $259
- Total revenue
- $283K
- Enterprise value
- $24.1M
Beyond the preview
Go deeper on Trevena, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trevena, Inc..